Reporter/Multiple Myeloma/car-t-cell-therapies-bispecific-antibodies-and-antibody-conjugates
CAR T-Cell Therapies, Bispecific Antibodies, and Antibody Conjugates
Source : https://expertperspectives.com/Conference
Aggressive B-Cell Non-Hodgkin Lymphoma: Molecular Profiling and Post-Treatment Surveillance
An update on B-cell maturation antigen-targeted therapies in Multiple Myeloma
Source : https://doi.org/10.1080/14712598.2021.1872540
ABSTRACT Introduction: B-cell maturation antigen (BCMA) targeted therapy (BCMA-TT) has emerged as a promising treatment for Multiple Myeloma (MM). the three most common treatment modalities for targeting BCMA are antibody-drug...
Imaging Techniques for Response Assessment and Follow-Up
Source : https://link.springer.com/chapter/10.1007/978-3-030-63662-3_5
Leo Rasche Anke Heidemeier Stefan Delorme Niels Weinhold A recent study in newly diagnosed multiple myeloma (MM) patients revealed that high-risk tumor clones can be restricted to focal lesions (FLs)...
New Perspectives in Imaging Techniques
Source : https://link.springer.com/chapter/10.1007/978-3-030-63662-3_6
Bastien Jamet Clément Bailly Thomas Carlier Anne-Victoire Michaud Cyrille Touzeau Philippe Moreau Caroline Bodet-Milin Françoise Kraeber-Bodéré The development of nuclear medicine offers new perspectives in multiple myeloma (MM) imaging. New...
Treatment of Multiple Myeloma with Kidney Involvement
Source : https://link.springer.com/chapter/10.1007/978-3-030-63662-3_10
Mark A. Cook In many respects, the treatment of myeloma in patients with kidney involvement and renal impairment has the same goal as any other patient group being treated for...